ALDX FY 2018 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ALDXAldeyra Therapeutics, Inc.

$290M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$71,003

Operating Income

-$40M

Net Income

-$39M

EPS (Diluted)

$-1.79

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$95M

Total Liabilities

$8M

Stockholders' Equity

$87M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$71,003	-$37,849	-87.6%
Operating Income	-$40M	-$22M	-76.5%
Net Income	-$39M	-$22M	-74.1%